T (Tom) Belleman

Erasmus School of Health Policy & Management

PhD candidate | Health Technology Assessment (HTA)

Dianne Bosch, Kim J.M. van der Velden, Tom Belleman, Welmoed K. van Deen, André M Bergman, Maarten J. van der Doelen, Alfons J M van den Eertwegh, Winald R Gerritsen, Reindert J A van Moorselaar, Diederik M. Somford, Metin Tascilar, Hans M. Westgeest, Carin A Uyl-de Groot, Peter F.A. Mulders, Malou C.P. Kuppen & Inge M. van Oort (2025) - Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Clinical Genitourinary Cancer - doi: 10.1016/j.clgc.2025.102317
Elaine Julian, Tom Belleman, Maria João Garcia, Robin Doeswijk, Rosa Giuliani, Bernhard J. Woermann, Daniel Widmer, Patrick Tilleul, Ruben Casado-Arroyo, Valentina Strammiello, Kate Morgan, Marcus Guardian, Michael Ermisch, Renato Bernardini, Fabrizio Gianfrate, Stefano Capri, Carin de Groot, Mira Pavlovic, Jörg Ruof & Maureen van Molken (2025) - Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy - Journal of Market Access and Health Policy, 5, 1-16
Tom Belleman, Jeroen van Wijngaarden, Malou C.P. Kuppen, Saskia de Groot, Kim J. M. van der Velden, Dianne Bosch, Inge M. van Oort, Carin Uyl - de Groot & Welmoed van Deen (2025) - Moving from a registry to a learning health system: A casestudy of a Dutch prostate cancer registry - Learning Health Systems - doi: 10.1002/lrh2.10476 - [link]